Literature DB >> 18209576

Genetic variation within the beta1-adrenergic receptor gene results in haplotype-specific expression phenotypes.

Kersten M Small1, Jeanne Mialet-Perez, Stephen B Liggett.   

Abstract

Cardiac beta1-adrenergic receptor (beta1AR) responsiveness in heart failure exhibits interindividual variation that may be attributable to polymorphisms of the intronless beta1AR gene. We sought to ascertain the polymorphisms of the full-length gene and the specific combinations of polymorphisms (haplotypes) in two reference populations. Using whole-gene transfections, we established the impact of beta1AR polymorphisms, within the context of haplotypes, on receptor expression. Fifteen polymorphisms within the 6.1-kb gene with allele frequencies > or =0.05 were found in the 5'-flanking and coding regions, but none in the 3'UTR. These were organized into six common haplotypes. Ethnic-specific and cosmopolitan polymorphisms and haplotypes were noted. Whole-gene transfections of A431 cells revealed an association between haplotype and expression, with as much as twofold differences in expression. Phenotypes clustered into three groups, representing high (two haplotypes), intermediate (three haplotypes), and low (one haplotype) expression. We conclude that the beta1AR gene is highly polymorphic and is commonly found in six haplotypic forms in the population. Receptor expression varies by haplotype, which provides the foundation for cardiovascular association studies with enhanced predictive power using beta1AR haplotypes, or haplotype expression clusters, as compared with individual polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18209576     DOI: 10.1097/FJC.0b013e31815a958f

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  6 in total

Review 1.  Mechanisms of pharmacogenomic effects of genetic variation within the cardiac adrenergic network in heart failure.

Authors:  Gerald W Dorn; Stephen B Liggett
Journal:  Mol Pharmacol       Date:  2009-06-02       Impact factor: 4.436

2.  S49G and R389G polymorphisms of the β₁-adrenergic receptor influence signaling via the cAMP-PKA and ERK pathways.

Authors:  Fan Zhang; Susan F Steinberg
Journal:  Physiol Genomics       Date:  2013-10-22       Impact factor: 3.107

Review 3.  Pharmacogenomics of beta1-adrenergic receptor polymorphisms in heart failure.

Authors:  Stephen B Liggett
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

4.  Analysis of the role of interleukin 6 receptor haplotypes in the regulation of circulating levels of inflammatory biomarkers and risk of coronary heart disease.

Authors:  Bruna Gigante; Rona J Strawbridge; Ilais Moreno Velasquez; Zahra Golabkesh; Angela Silveira; Anuj Goel; Damiano Baldassarre; Fabrizio Veglia; Elena Tremoli; Robert Clarke; Hugh Watkins; Anders Hamsten; Steve E Humphries; Ulf de Faire
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

5.  Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survival.

Authors:  Sharon L R Kardia; Reagan J Kelly; Mehdi A Keddache; Bruce J Aronow; Gregory A Grabowski; Harvey S Hahn; Karen L Case; Lynne E Wagoner; Gerald W Dorn; Stephen B Liggett
Journal:  BMC Med Genet       Date:  2008-10-23       Impact factor: 2.103

6.  Levels of human platelet-derived soluble CD40 ligand depend on haplotypes of CD40LG-CD40-ITGA2.

Authors:  Chaker Aloui; Antoine Prigent; Sofiane Tariket; Caroline Sut; Jocelyne Fagan; Fabrice Cognasse; Tahar Chakroun; Olivier Garraud; Sandrine Laradi
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.